Titan Medical (TSX:TMD;OTC:TITFX) announced today that it appointed Deepak Basra as its VP of strategy and business development.
In the newly created role, Basra’s responsibilities include overseeing Toronto-based Titan’s corporate development and strategic planning, according to a news release.
Basra joins the company as a veteran of more than 20 years in global business development and mergers & acquisitions, having most recently held the role of SVP with Cortland Advisers, an M&A advisory firm. He previously served as board director & VP of strategy & business development at Transdermal Delivery Solutions. Before that, he operated as head of business development & licensing for Covidien’s vascular therapies division.
Before Covidien, Basra served as SVP of strategy & business development at Smith+Nephew and held several roles at Cable & Wireless, British Telecommunications and Phillips.
“We are thrilled to welcome Deepak to Titan. His wealth of knowledge and experience in business development and strategic partnerships will be instrumental in growing Titan,” Titan Medical president & CEO David McNally said in the release. “We look forward to Deepak’s contributions as we execute on our vision of advancing our Enos robotic single access surgery system.”